Experiences with recombinant factor VIII products: development of inhibitors and immune tolerance therapy.
Scharrer
I
I
Neutzling
O
O
Schwaab
R
R
Oldenburg
J
J
Ehrlich
H
H
D005169:Factor VIII / Q000037:antagonists & inhibitors*; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans; D011994:Recombinant Proteins / Q000627:therapeutic use
D011994:Recombinant Proteins; D005169:Factor VIII